Advances in the structure‐activity relationships, mechanisms of action, and therapeutic utilities of ATP‐sensitive potassium channel openers

Drug Development Research

Volumn 33, Issue 3, 1994, Pages 250-262

  Atwal, Karnail S ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

KATP; potassium channel openers; structure activity relationships

Indexed keywords

1 (N2 NICOTINOYLLYSYL GAMMA DEXTRO GLUTAMYL)OCTAHYDRO 1H INDOLE 2 CARBOXYLIC ACID; 2 CYANO 1 (4 CYANOPHENYL) 3 (1,2,2 TRIMETHYLPROPYL)GUANIDINE; 3 CYANO 1 (4 CYANOPHENYL) 2 (1,2,2 TRIMETHYLPROPYL)GUANIDINE; 3,4 DIHYDRO 2,2 DIMETHYL 4 (2 OXO 1 PIPERIDINYL) 6 PENTAFLUOROETHYL 2H 1 BENZOPYRAN 3 OL; 8 TERT BUTYL 6,7 DIHYDRO 5 METHYLPYRROLO[3,2 E]PYRAZOLO[1,5 A]PYRIMIDINE 3 CARBONITRILE; ANTIHYPERTENSIVE AGENT; APRIKALIM; CROMAKALIM; DIAZOXIDE; KN 399; MINOXIDIL; NICORANDIL; NIFEDIPINE; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL AFFECTING AGENT; RP 66266; RP 66784; UNCLASSIFIED DRUG;

AORTA; ASTHMA; CHANNEL GATING; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RABBIT; REVIEW; SMOOTH MUSCLE RELAXATION; URINE INCONTINENCE;

EID: 0027996824     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430330308     Document Type: Article

References (106)

1. + channel openers on the vascular actions of human gamma globulin
2. Dialkylnaphthalen‐1‐ones as new potassium channel activators
3. 3H]glibenclamide in the rat cereberal cortex does not recognize K‐channel agonists or antagonists other than sulfonyl ureas
4. Adenosine 5′‐triphosphate‐sensitive potassium channels
5. Modulation of potassium channels by organic molecules
6. Aryl cyanoguanidine potassium channel openers
7. Benzopyranyl‐cyanoguanidine potassium channel openers
8. The discovery of a novel calcium channel blocker related to the structure of potassium channel opener cromakalim
9. Cardioselective anti‐ischemic ATP‐sensitive potassium channel openers
10. Inhibition of histamine induced bronchoconstriction in normal healthy volunteers by a potassium channel activator, cromakalim, BRL 34915
11. + channels reduce anoxic depolarization in CA3 hippocalpal neurons
12. + channel
13. Comparison of the airway relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea pigs and rats
14. + channel openers in rat aorta
15. Synthesis and biological activities of potent potassium channel openers derived from (±)‐2‐oxo‐1‐pyridine‐3‐yl‐cyclohexanecarbothioic methylamide: New potassium channel openers
16. Benzopyran potassium channel activators related to cromakalim‐amide replacements at position 4
17. Structure and function of voltage‐sensitive ion channels
18. Regulation of ATP sensitive potassium channel of isolated guinea pig ventricular myocytes by sarcolemmal monocarboxylate transport
19. + channel blockers and activators in cardiac arrhythmias
20. The pharmacology of potassium channels and their therapeutic applications
21. Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma
22. + channels in pancreatic B‐cells
23. Hypoxic dilation of coronary arteries is mediated by ATP‐sensitive potassium channels
24. + channels in insulinoma cells: Activation by somatostatin and protein kinase C and the role of cAMP
25. 3H]P1075
26. Medical treatment of peripheral vascular disease: Good or bad
27. Potassium channel activation in the vascular smooth muscle cell‐membrane: A new mechanism of action in antihypertensive treatment. Early clincal results with BRL 34915
28. + channels
29. Inductionof a glibenclamide‐sensitive K‐current by modification of a delayed rectifier channel in rat portal vein and insulinoma cells
30. Levcromakalim may induce a voltage‐independent K‐current in rat portal vein by modifitying the gating properties of the delayed rectifier
31. Suppression of repolarization related arrhythmias in vitro and in vivo by low dose potassium channel activators
32. The effects of cromakalim on the detrusor muscle of human and pig urinary bladder
33. ATP potassium channel openers
34. The heart in hypertension: A1991 overview
35. Is reversal of left ventricular hypertrophy in hypertension beneficial
36. Synthesis and biological activity of spirocyclic benzopyran imidazolone potassium channel openers
37. + channel openers epilepsy induced by bee venom peptide MCD
38. + channel openers decrease seizures in genetically epileptic rats
39. Pinacidil with and without hydrochlorothiazide. Dose‐response relationships from results of 4 x 3 factorial design study
40. + channels: Pharmacological properties, regulation, and therapeutic potential
41. + conductance improves in vitro the contraction force of skeletal muscle in hypokalemic periodic paralysis
42. Anilide tertiary carbinols: A new structural class of potent potassium channel openers
43. Blockade of ATP‐sensitive channels prevents myocardial preconditioning in dogs
44. Protective effects of a cardioselective ATP‐sensitive potassium channel opener BMS‐180448 in two stunned myocardium models
45. Anti‐ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide
46. + channel activators cromakalim and pinacidil in dog and isolated rat hearts
47. Pharmacological profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs
48. Reduction of ischemic damage in isolated rat hearts by potassium channel opener, RP 52891
49. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs
50. +‐channel openers: New antihypertensive drugs
51. Cromakalim reverses ischemic depression of skeletal muscle contractions in the rat hind limb
52. Effects of pinacidil on detrusor instability in men with bladder outlet obstruction
53. + channel openers prevent global ischemia‐induced expression of c‐fos, c‐jun, heat shock protein, and amyloid β‐protein precursor genes and neuronal death in hippocampus
54. High affinity binding of a potassium channel agonist to intact rat insulinoma cells
55. + channel opener acts as a potent Cl‐ channel inhibitor in vascular smooth muscle cells
56. + channel opener, KC 339, in the guinea pig
57. Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: A 6‐month double blind comparison
58. Lactate activates ATP‐sensitive potassium channels in guinea pig ventricular myocytes
59. + channels in cardiac myocytes by free fatty acids
60. + channels to Al receptors by G proteins in rat ventricular myocytes
61. Effects of LP‐805, a novel vasorelaxant agent, a potassium channel opener, on rat thoracic aorta
62. + channel openers by pharmacophore model
63. + channel openers
64. + channel opener with long duration of action and less tachycardia
65. N, N‐Disubstituted benzopyran‐4‐(N'‐cyano)carboxamidines, cromakalim analogs with selective activity for guinea pig trachealis
66. Adensosine triphosphate‐sensitive potassium channels in anoxia
67. In vitro cardiac models of dog purkinje fibre triggered and spontaneous electrical activity: Effects of nicorandil
68. Synthesis and radioligand binding studies with a tritiated pinacidil analogue: Receptor interaction of structurally different classes of potassium channel openers and blockers
69. Specific block of the antiischemic‐actions of cromakalim by sodium 5‐hydroxydecanoate
70. + channels in insulinoma cells are activated by nonesterified fatty acids
71. + channels‐related mechanism in its antihypertensive and cough‐suppressant effects
72. + channel opener
73. + channels in cardiac muscle
74. + channel
75. The effect of cromakalim on normal and hyperreflexic human detrusor muscle
76. Glibenclamide and procaine, but not apamine, inhibit the relaxant responses to Ro 31–6930 in guinea‐pig taenia caeci
77. Effects of several potassium channel openers and glibenclamide on the uterus of the rat
78. 3‐(Alkylamino)‐4H‐pyrido[4,3‐e]‐1,2,4‐thiadiazine 1,1‐dioxide as powerful inhibitors of insulin release from rat pancreatic B‐cells: A new class of potassium channel openers
79. + channels
80. + openers
81. + channel opener [3H]P1075 in rat isolated aorta: Relationship to functional effects of openers and blockers
82. + channel openers suppress myotonic activity of human skeletal muscle in vitro
83. Conservative management of intermittent claudication
84. Potassium channel openers: Airway pharmacology and clinical possibilities in asthma
85. The effect of cromakalim on human detrusor: An in vitro and in vivo study
86. ATP mediates both activation and inhibition of K(ATP) channel activity via cAMP‐dependent protein kinase in insulin‐sereting cell lines
87. Effects of tachykinins on mucus secretion in human bronchi in vitro
88. Thiophene systems. 14. Synthesis and antihypertensive activity of a novel 7‐(cyclic amido)‐6‐hydroxythieno[3,2‐b]pyrans and related compounds as new potassium channel activators
89. + channel openers
90. Structural and functional consequences of minoxidil‐induced cardiac hypertrophy
91. The use of β‐agonists and the risk of death and near death from asthma
92. Studies of the unitary properties of adenosine‐5′‐triphosphate‐regulated potassium channels of frog skeletal muscle
93. Cromakalim (BRL 34915) restores in vitro membrane potential of depolarized human skeletal muscle fibres
94. Novel potassium channel openers: Synthesis and pharmacological evaluation of new N‐(substituted‐3‐pyridyl)‐N'‐alkylthioureas and related compounds
95. An investigation of the selectivities of BRL 55834 and BRL 38227 as relaxants of guinea‐pig tracheal spirals relative to portal vein
96. Potassium channel activators lower blood pressure: An initial study of BRL 34915 in hypertensive patients
97. + channels
98. + channel by protein kinase A and C
99. Renal potassium channels and their regulation
100. + channels
101. Inhibition of nocturnal asthma by relaxation of airway smooth muscle with a potassium channel activator
102. Influence of ATP‐sensitive potassium channel modulators on ischemia‐induced fibrillation in isolated rat hearts
103. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs